EP Patent

EP0162388A1 — Novel bile sequestrant resin and uses

Assigned to Bristol Myers Co · Expires 1985-11-27 · 40y expired

What this patent protects

Particular quaternized vinylimidazole-ethylene glycol dimethacrylate copolymers are useful to sequester non-absorbed bile acids in the intestinal tract to form a complex which is excreted in the feces. These are of particular interest for lowering blood cholesterol levels. Some o…

USPTO Abstract

Particular quaternized vinylimidazole-ethylene glycol dimethacrylate copolymers are useful to sequester non-absorbed bile acids in the intestinal tract to form a complex which is excreted in the feces. These are of particular interest for lowering blood cholesterol levels. Some of these copolymers have the further useful property of being excellent anti-diarrheal agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP0162388A1
Jurisdiction
EP
Classification
—
Expires
1985-11-27
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.